The Global Market for Surfing is Projected to Reach US$9.5 Billion by 2022

The global market for Cardiac Ablation is projected to reach US$1.4 billion by 2025, driven by the growing burden of cardiovascular diseases worldwide. Apart from circulatory disorders caused by high blood pressure and coronary artery disease such as blockages in arteries, electrical disorders, also known as conduction disorders of the heart are also a major class of cardiovascular disease. Arrhythmias/abnormal/irregular heart rhythms can sometimes be fatal when not treated properly. Electrical impulses travel through the heart to control the heartbeat. When disruptions in the electrical flow occur it results in irregular heartbeat and rhythm. In a normal heart, electrical impulses travel down the right and left branches of the ventricles at the same speed allowing both the ventricles to contract simultaneously. When a block is encountered in the one of the ventricles, the electrical signal is rerouted through a different path result in the one ventricle contracting slower that the other resulting in arrhythmia. Arrhythmias such as Tachycardia and Bradycardia are often treated with medications, such as beta blockers and/or through surgical implantation of cardioverter defibrillator (ICD) or pacemaker. Cardiac ablation significantly improves the chances of survival of patients with atrial fibrillation. Companies are developing robotic catheter systems that will enable more stable and precise steerability of the catheter. Robotic surgical ablation systems bring numerous benefits such as smaller incisions, eliminates catheter-tissue contact issues, higher catheter stability when compared to manual manipulation, reduced fluoroscopy exposure, ability to remotely steer the catheter, and reduction in operator error. Read More…